These stocks are likely to be in focus on December 6
Last Updated: 3rd December 2021 - 04:54 pm
On Friday, the benchmark indices broke the two-day positive streak and ended lower with Sensex closing below the 58,000 mark.
Closing for the week, the Sensex was down 764.83 points or 1.31% at 57,696.46, and the Nifty was down 205 points or 1.18% at 17,196.70. About 1722 shares have advanced, 1453 shares declined, and 137 shares are unchanged.
On the sectoral front, all the indices ended in the red apart from capital goods. Adani Green was the top gaining stock in the capital goods sector zooming 4.14%.
In the broader markets, BSE Midcap and Smallcap indices ended on a flat note.
Watch out for these stocks in Monday’s trading session:
Biocon – The company announced that Biocon Pharma, a subsidiary of Biocon, received approval of its ANDA for Mycophenolic Acid from the USFDA. This product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available in 180mg and 360mg strengths. This approval further adds to Biocon’s portfolio of vertically integrated complex drug products. The share traded flat in Friday’s trading session and are likely to be in focus on Monday.
Hero MotoCorp – The company has announced that along with Gilera Motors Argentina, it has expanded operations and inaugurated a flagship dealership in Argentina. The company had recently announced the revitalization of its presence in Argentina by partnering with Gilera Motors, one of the leading companies in the motor vehicle sector in Argentina and one of the most experienced motorcycle manufacturers in Latin America. The company has ended 0.29% lower in Friday’s trading session.
52-week high stocks – From the BSE 100 pack, the stocks of Bajaj Holdings, Power Grid Corporation of India and Tech Mahindra have made fresh 52-week high prices. Keep a watch on these stocks for Monday’s trading session.
Trending on 5paisa
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.